Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro

Cancer Letters

Volumn 233, Issue 2, 2006, Pages 255-264

  Papazisis, Konstantinos T ^a,b,d   Kalemi, Theodora G ^b   Zambouli, Dimitra ^a   Geromichalos, George D ^a   Lambropoulos, Alexandros F ^b   Kotsis, Alexandros ^b   Boutis, Lazaros L ^b   Kortsaris, Alexandros H ^c  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Camptothecins; Cell cycle; Cell line; Genistein; Synergism

Indexed keywords

CAMPTOTHECIN; GENISTEIN; HERBIMYCIN; IRINOTECAN; PROTEIN TYROSINE KINASE INHIBITOR; TOPOTECAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL POPULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CAMPTOTHECIN; CDC2 PROTEIN KINASE; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; FEMALE; FIBROBLASTS; G2 PHASE; GENISTEIN; HELA CELLS; HUMANS; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES;

ANIMALIA;

EID: 33644659108     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.03.022     Document Type: Article

References (49)

1. B.J. Druker, M. Talpaz, D.J. Resta, B. Peng, E. Buchdunger, and J.M. Ford Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia N. Engl. J. Med. 344 2001 1031 1037
2. B.J. Druker, C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, and J.M. Ford Activity of a specific inhibitor of the bcr-abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N. Engl. J. Med. 344 2001 1038 1042
3. H. Joensuu, and S. Dimitrijevic Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumors Ann. Med. 33 2001 451 455
4. A.J. Barker, K.H. Gibson, W. Grundy, A.A. Godfrey, J.J. Barlow, and M.P. Healy Studies leading to the identification of ZD1839 (IressaTM), An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer Bioorg. Med. Chem. Lett. 11 2001 1911 1914
5. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Itoh Genistein, a specific inhibitor of tyrosine-specific protein kinases J. Biol. Chem. 226 1987 5592 5595
6. M.H. Ravindranath, S. Muthugounder, N. Presser, and S. Viswanathan Anticancer therapeutic potential of soy isoflavone, genistein Adv. Exp. Med. Biol. 546 2004 121 165
7. T. Dorai, and B.B. Aggarwal Role of chemopreventive agents in cancer therapy Cancer Lett. 215 2004 129 140
8. T. Akiyama, and H. Ogawara Use and specificity of genistein as inhibitor of protein-tyrosine kinases Methods Enzymol. 201 1991 362 370
9. J. Markovits, C. Linassier, P. Fosse, J. Couprie, J. Pierre, and A. Jacquemin-Sablon Inhibitory effects of tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Res. 49 1989 5111 5117
10. J. Markovits, A.K. Larsen, E. Segal-Bendirdjian, P. Fosse, J.-M. Saucier, and A. Gazit Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives Biochem. Pharmacol. 48 1994 549 560
11. H. Adlercreutz, C. Bannwart, T. Wähälä Mäkelä, G. Brunow, T. Hase, and P.J. Arosemena Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens J. Steroid Biochem. Mol. Biol. 44 1993 147 153
12. A. Cassidy, S. Bingham, and K.D.R. Setchell Biological effect of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women Am. J. Clin. Nutr. 60 1994 333 340
13. Y. Matsukawa, N. Marui, T. Sakai, Y. Satomi, M. Yoshida, and K. Matsumoto Genistein arrests cell cycle progression at G2-M Cancer Res. 53 1993 1328 1331
14. A.I. Constantinou, N. Kamath, and J.S. Murley Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells Eur. J. Cancer 34 1998 1927 1934
15. F. Lian, M. Bhuiyan, Y.W. Li, N. Wall, M. Kraut, and F.H. Sarkar Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line Nutr. Cancer 31 1998 184 191
16. K.T. Papazisis, D. Zambouli, O.T. Kimoundri, E.S. Papadakis, V. Vala, and G.D. Geromichalos Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with γ-irradiation Cancer Lett. 160 2000 107 113
17. T. Akimoto, T. Nonaka, H. Ishikawa, H. Sakurai, J.I. Saitoh, T. Takahashi, and N. Mitsuhashi Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways Int. J. Radiat. Oncol. Biol. Phys. 50 2001 195 201
18. G.G. Hillman, J.D. Forman, O. Kucuk, M. Yudelev, R.L. Maughan, and J. Rubio Genistein potentiates the radiation effect on prostate carcinoma cells Clin. Cancer Res. 7 2001 382 390
19. V. Dangles, F. Femenia, V. Laine, M. Berthelemy, D. Le Rhun, and M.F. Poupon Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines Cancer Res. 57 1997 3360 3364
20. T. Hiwasa, Y. Aras, Z. Chen, K. Kita, K. Umezawa, H. Ito, and N. Suzuki Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors Fed. Eur. Biol. Soc. Lett. 444 1999 173 176
21. E.S. Papadakis, K.T. Papazisis, G.D. Geromichalos, K.A. Dimitriadis, A.H. Kortsaris, Signal transduction modification and apoptosis after UV irradiation in K562 and Raji cell lines. In: Proceedings of 9th International Congress on Anti-Cancer Treatment, Paris, February 2-5, 1999. pp. 292.
22. W. Lei, J.E. Mayotte, and M.L. Levitt Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells Anticancer Res. 19 1999 221 228
23. S. Khoshyomn, D. Nathan, G.C. Manske, T.M. Osler, and P.L. Penar Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells J. Neurooncol. 57 2002 193 200
24. Y. Liu, K. Bhalla, C. Hill, and D.G. Priest Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line Biochem. Pharmacol. 48 1994 1265 1272
25. J.F. Pizzolato, and L.B. Saltz The camptothecins Lancet 361 2003 2235 2242
26. A.Y. Chen, and L.F. Liy DNA topoisomerases: essential enzymes and lethal targets Annu. Rev. Pharmacol. Toxicol. 34 1994 191 208
27. G.O. Gey, W.D. Coffman, and M.T. Kubicek Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium Cancer Res. 12 1952 264
28. A.P. Wilson Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary J. Natl Cancer Inst. 72 1984 513 521
29. W.R. Earle, E.L. Schilling, T.H. Stark, N.P. Straus, M.F. Brown, and E. Shelton Production of malignancy in vitro. IV. The mouse fibroblast cultures and changes seen in the living cells J. Natl Cancer Inst. 4 1943 165
30. K.K. Sanford, W.R. Earle, and G.D. Likely The growth in vitro of single isolated tissue cells J. Natl Cancer Inst. 9 1948 229
31. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, and D. Vistica New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl Cancer Inst. 82 1990 1107 1112
32. K.T. Papazisis, G.D. Geromichalos, K.A. Dimitriadis, and A.H. Kortsaris Optimization of the sulforhodamine B colorimetric assay J. Immunol. Methods 208 1997 151 158
33. J.P. Magaud, I. Sargent, and D.Y. Mason Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake J. Immunol. Methods 106 1998 95 100
34. T.-C. Chou, and P. Talalay A simple generalized equation for the analysis of multiple inhibitors of Michaelis-Menten kinetic systems J. Biol. Chem. 252 1997 6438 6442
35. T.-C. Chou, and P. Talalay Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors Eur. J. Biochem. 115 1981 207 216
36. J. Chou, T.-C. Chou, Dose-effect analysis with microcomputers: Quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor-ligand binding and enzyme kinetics. Manual and Software 'CalcuSyn', Biosoft, Cambridge, UK, 1987.
37. H.A. Crissman Cell cycle analysis by flow cytometry G.P. Studzinski Cell Growth and Apoptosis. A Practical Approach 1995 Oxford University Press, Inc. New York 22 23
38. H.A. Crissman, and J.A. Steinkamp Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations J. Cell Biol. 59 1973 766 771
39. A. Krishan Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining J. Cell Biol. 66 1975 188 193
40. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
41. S.H. Kaufmann, S. Desnoyers, Y. Ottaviano, N.E. Davidson,G, and G. Poirier Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res. 53 1993 3976 3985
42. D.W. Nickolson, and N.A. Thornberry Caspases: killer proteases Trends Biochem. Sci. 22 1997 299 306
43. G. Condorelli, A. Trencia, G. Vigliotta, A. Perfetti, U. Goglia, and A. Cassese Multiple members of the mitogen activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function J. Biol. Chem. 277 2002 11013 11018
44. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
45. G. Iliakis Cell cycle regulation in irradiated and non-irradiated cells Semin. Oncol. 24 1997 602 615
46. W.K. Kaufmann Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints Proc. Soc. Exp. Biol. Med. 217 1998 327 334
47. T. Kawabe G2 checkpoint abrogators as anticancer drugs Mol. Cancer Ther. 3 2004 513 519
48. T. Waldman, Y. Zhang, L. Dillehay, K. Kinzler, B. Vogelstein, and J. Williams Cell-cycle arrest versus cell death in cancer therapy Nat. Med. 3 1997 1034 1036
49. Y. Li, K.L. Ellis, S. Ali, B.F. El-Rayes, A. Nedeljkovic-Kurepa, O. Kucuk, P.A. Philip, and F.H. Sarkar Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line Pancreas 28 2004 e90 e95